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Abstract:  Analogous  to  the  evolution  of  biological  sensor-systems,  the  progress  in 
“medical  sensor-systems”,  i.e.,  diagnostic  procedures,  is  paradigmatically  described. 
Outstanding  highlights  of  this  progress  are  magnetic  resonance  imaging  (MRI)  and 
spectroscopy  (MRS),  which  enable  non-invasive,  in  vivo  acquisition  of  morphological, 
functional,  and  metabolic  information  from  the  human  body  with  unsurpassed  quality. 
Recent achievements in high and ultra-high field MR (at 3 and 7 Tesla) are described, and 
representative research applications in Medicine and Psychology in Austria are discussed. 
Finally, an overview of current and prospective research in multi-modal imaging, potential 
clinical applications, as well as current limitations and challenges is given. 
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1. Introduction 
Over thousands of years, natural sensors (our senses) have been shaped by evolution according to 
local  environments,  yielding  adjustments  and  improved  coping  capabilities  for  ordinary  and  new 
challenges. The performance of human sensor systems is still unsurpassed by technical sensors and 
sensor  systems  in  many  aspects,  for  example,  pattern  identification,  signal  to  noise  amplification, 
pattern completion, etc. This is likely due to the fact that the development of technical, in our case 
physical and chemical sensors and sensor systems to enable objective measures, began only about two 
centuries ago. In the course of medical practice and science a large number of sensing systems, i.e., 
diagnostic  techniques,  have  been  developed.  Examples  are  the  Riva-Rocci  technique,  ultrasound 
imaging, X-ray diagnostics, computed tomography, etc. Also in the field of psychology, new research 
approaches  such  as  psychophysiology  and  biological  psychology  have  evolved  in  parallel  with 
classical procedures, i.e., introspection or behavior observation. Since the paradigm shift in the late 
1940s and early 1950s from behaviorism to cognitive psychology, biological psychology, especially 
brain  research,  became  progressively  important  in  all  provinces  of  psychology—the  black  box  of 
behaviorism  is  in  the  process  of  being  opened  down  to  the  level  of  the  subcellular  processes  in  
the brain.  
By employing modern imaging equipment it is now possible to record and store huge data sets of 
complex information within a short period of time (e.g., several GB in about 15 minutes of functional 
MRI scanning in a single subject, which will be multiplied by up to a factor of 10 or so during data 
processing and further multiplied by the number of subjects included in a study). However, in order to 
make  use  of  the  wealth  of  “objective”  information  for  diagnostic  or  scientific  purpose,  all  data 
containing relevant information have to be appropriately reduced and interpreted by a trained clinician 
or scientist, primarily taking into account the needs of patients. Despite the fact that human brains are 
sufficiently genetically and anatomically similar to allow them to achieve a variety of tasks along 
various lines of thought, some brains develop sensor systems and data processing tools and some apply 
them and interpret the results, leading to a multi-disciplinary world which should help to gain more 
insight into the complexity of human functions and pathological changes in order to improve our life. 
Recent advancements in MR technology [1,2], in particular high-field magnetic resonance imaging 
and spectroscopy, allow multi-parameter, non-invasive 3D-scanning of the human body [3-5]. This 
versatile approach enables not only morphological but also functional and metabolic imaging within 
the same scanner session, as will be described in more detail below. Furthermore, MR technology has 
been the driving force in medical imaging for over 25 years. This not only stimulates research in MRI 
and MRS but also in other imaging modalities and even helps to integrate them whenever technically 
feasible and scientifically meaningful (e.g., MR-EEG, MR-PET). 
Using this technology with optimized measurement protocols and advanced data processing enables 
the function and metabolism of the human senses to be studied and explored, including variability and Sensors 2010, 10                        
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dysfunction, and how this contributes to human behavior. This, in turn, leads to a better understanding 
of  human  cognition  and  behavior,  improves  clinical  diagnostics,  and  helps  monitoring  therapeutic 
efficacy to improve patients’ quality of life. 
Here  we  have  come  full  circle—by  using  machinery  developed  by  the  human  brain  to  study 
unconsciously developed abilities, i.e., brain function, by means of complex physico-chemical sensor 
systems (for example, ultra-high magnetic field MR systems and protocols) and visualization software, 
whereas  medical  and  psychology  experts—familiar  with  the  technology,  their  potential  and 
shortcomings—have to interpret the data to make them useful for scientific and clinical purposes.  
Morphological MRI—Techniques and Applications  
Morphological  MRI  of  the  brain  is  a  powerful  method  in  assessing  atrophy  in  patient  cohorts, 
healthy subjects and normal aging [6,7]. There is no general rule about which contrast should be used 
to  assess  morphology,  but  generally  T1-weighted  images  are  used  to  segment  neuroanatomical 
structures  such  as  the  hippocampus,  gray/white  matter  boundaries  and  the  ventricles.  
T2 sequences provide high image intensity for structures, which are filled with cerebrospinal fluid 
(CSF) and is, therefore, suitable to segment the ventricles. MP-RAGE (Magnetization Prepared RApid 
Gradient  Echo) [8]  is  a  very  common  gradient  echo  sequence  used  to  acquire  T1-weighted  data.  
MP-RAGE uses a non-selective 180° pulse to prepare the magnetization in order to achieve a certain 
contrast followed by  a  RAGE (RApid Gradient Echo) sequence for image  acquisition. The major 
advantage of MP-RAGE is that it can be used for 3D image acquisition, increasing the signal to noise 
ratio (SNR) in proportion with the number of slices. Another advantage of MP-RAGE is that gradient 
echoes are used for data acquisition, which is important in order to keep the Specific Absorption Rate 
(SAR; see Appendix) low. This is especially important for ultra-high field MR-systems (>3 T). The 
achievable image resolution using MP-RAGE under clinical conditions, with scan times of about 10-
15 min for the brain, is about 0.80 mm isotropic (0.51 mm
3) on a 3 T system and 0.65 mm isotropic 
(0.27 mm
3) on a 7 T system.  
In  order  to  acquire  T2-weighted  data,  Turbo  Spin  Echo  (TSE)  or  Fast  Spin  Echo  (FSE) 
measurement sequences [9] are mainly used, where TSE and FSE are in principal very similar, the 
difference in naming being a manufacturers’ convention. As T2-weighted sequences work with spin 
echoes, requiring higher RF-energy, the SAR limit can be reached easily on 3 T systems. This problem 
becomes even worse on 7 T systems where only a small number of slices can be acquired without 
exceeding the SAR limit. Currently, there are a number of methods under development in order to 
reduce the RF energy deposition and to acquire T2-weighted data on 7 T systems [10]. 
Susceptibility Weighted Imaging (SWI) is a novel imaging technique that involves both MRI and 
image  processing,  exploiting  the  magnetic  susceptibility  difference  between  different  tissues  to 
enhance contrast in MR magnitude images [11].  
Magnetic susceptibility, which is the degree of magnetization of a substance in response to an 
external  magnetic  field  B0,  depends  on  the  tissue’s  chemical  composition,  state,  and  density.  A 
difference in magnetic susceptibility between neighboring tissues produces a different signal phase that 
is proportional to the echo time (TE) and the magnetic field strength B0. This phase difference can be 
measured and reconstructed as an image using a SWI protocol. Unlike commonly acquired magnitude Sensors 2010, 10                        
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images, SWI does not require additional scan time as complex data, i.e., magnitude and phase, are 
acquired in one scan. Phase images extracted from this complex data are used to enhance contrast in 
MR magnitude images, but also provide clinically interesting contrast in their own right. 
SWI has clear advantages as a high field method, as contrast is proportional to the magnetic field 
strength B0, and a gradient-echo sequence is used for data acquisition which allows high resolution 
imaging on 7 T systems without running into SAR limits. These features shall enable new insights to 
be gained into Parkinson's [12] and Alzheimer's diseases [13-15], where associated iron accumulations 
can be mapped with high spatial resolution, and in Multiple Sclerosis, in which lesion-related venous 
vessels can be visualized. Also, imaging micro bleeds (trauma) or monitoring the neurovascular system 
of a growing, malignant tumor is feasible. SWI images are sometimes displayed using the minimum 
intensity  projection  (mIP)  of  several  slices,  which  is  then  called  HRBV  (high-resolution  BOLD 
venography) [16,17].  To  date,  SWI  has  been  used  in  MR  venography [16],  arterial  venous 
malformations [18], occult venous disease [17], multiple sclerosis [19], tumors [20,21], and brain iron 
mapping [22-24]. 
Advanced Morphological Imaging of Joints and Cartilage 
Recently, high- and ultra-high-ﬁeld whole-body MR imaging systems have played an increasingly 
important role in musculoskeletal imaging. However, ultra-high field imaging systems are currently 
only used in research centers. In clinical settings, 1.5 T scanners have been the gold standard for 
musculoskeletal MR imaging, but are now increasingly being replaced by 3 T systems. The major 
advantage  of  MR  imaging  systems  at  3  T  and  above  is  the  increased  capability  to  perform  high 
resolution morphological and especially biochemical imaging.  
At 1.5 T, most musculoskeletal tissues (e.g., cartilage, muscle, menisci, bone, tendon, ligaments) 
are rendered with quite a low signal-to-noise ratio (SNR). Modern 3 T systems offer not only an 
increase  in  field  strength,  but  also  have  advanced  radiofrequency  coil  designs,  and  new  imaging 
sequences. These yield increased SNR, which can be translated into either higher temporal or spatial 
resolution for improved morphological imaging. The ﬁeld strength dependent SNR gain is outweighed 
by the frequency dependency of relaxation times, and there is the need to adjust sequence parameters 
(e.g., bandwidth, RF pulse parameters) to reduce artifacts, and not exceed SAR limits.  
Imaging  the  knee:  MRI  at  1.5  T  already  provides  very  high  image  quality  for  knee  imaging. 
Eckstein et al., however, evaluated the precision of assessment of cartilage volume, thickness, and 
surface area of the femorotibial cartilage at 1.5 T and 3 T, and found that results tend to be more 
reproducible at 3 T than at 1.5 T [25]. 
Chang et al. performed the first in vivo 7 T MRI study of the knee. They investigated the trabecular 
bone microarchitecture, and detected activity-related changes in Olympic fencers compared to healthy 
controls [26]. It has been shown that dual X-ray measurement of bone density, as currently used for the 
diagnostics of osteoporosis, is not sufficient to characterize bone quality, because, apart from the bone 
density, the trabecular bone architecture contributes significantly to the mechanical strength, and thus, 
fracture  risk  [27,28].  Such  bone  structure  is  routinely  characterized  by  microscopic  computed 
tomography [29,30]. However, in vivo trabecular bone imaging is one of the emerging applications for Sensors 2010, 10                        
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high-resolution morphological MRI; this application—due to the increased sensitivity to susceptibility 
and  the  resulting  shortened  T2*  relaxation  times—truly  benefits  from  moving  to  a  higher  field 
strength [31,32].  
For  cartilage  imaging,  up  to  a  2.4-fold  increase  in  SNR  has  been  reported  in  fully  balanced  
steady-state, free-precession imaging comparing 3 T and 7 T. One study detected an increase in SNR 
from  3  T  to  7  T  that  was  significant  only  for  the  gradient-echo,  but  not  for  the  fast  spin-echo 
sequences [33]. In that comparison, however, scan parameters for the fast spin-echo sequence had to 
be modified due to SAR limits, which resulted in incomplete coverage of the knee joint, extensive 
artifacts, and a less effective fat saturation. Contrast-to-noise ratio (CNR) and image quality were 
increased for the gradient-echo and decreased for the fast spin-echo sequences. When comparing 3 T 
and 7 T, the level of confidence for diagnosing cartilage lesions was higher in the gradient-echo and 
lower in the fast spin-echo sequences; however, overall, the fast spin-echo sequences at 3 T had the 
highest confidence score. Evaluation of bone marrow edema was decreased at 7 T due to the limited 
performance of the fast spin-echo sequences. 
Kraff et al. have performed a comparison between knee imaging at 1.5 T and 7 T and also reported 
that, due to the SAR limitations with the fast spin-echo sequences, subsequent measurements were 
needed for complete coverage of the knee joint [34]. They also confirmed that bone marrow edema 
was better visualized at 1.5 T than at 7 T. To date, no study has verified a statistically significant 
increase in diagnostic accuracy for the detection of common pathologies in the knee when moving to 
MR scanners with field strengths above 3 T.  
Imaging the ankle: Bauer et al. performed trabecular bone imaging of the calcaneus and concluded 
that 3 T results were more accurate than those calculated from the 1.5 T [35]. Notably, the advances in 
visualizing trabecular bone structure were partially SNR-independent. They assumed that the better 
performance  at  3  T  might  have  been  due  to  increased  sensitivity  to  susceptibility,  enhancing  the 
visualization  of  thin  trabecular  structures.  The  same  group  published  data  indicating  that  ankle 
abnormalities are better visualised at 3 T than at 1.5 T, and applying parallel imaging reduced the scan 
time by 56% [36]. 
Another group confirmed that image quality for imaging the ankle was significantly higher at 3 T 
than at 1.5 T [37]. In two of four readers, the sensitivity in detecting cartilaginous pathology at the 
ankle joint was enhanced significantly by imaging at 3 T compared to 1.5 T, using a fast spin-echo 
sequence. Differences between 1.5 T and 3 T when balanced Steady-State Free Precession (bSSFP) 
and the Spoiled Gradient Recalled (SPGR) sequences were used were insignificant, based on ratings 
by  all  the  radiologists  in  that  study.  The  sensitivities  for  detecting  tendon  pathologies  were 
significantly  higher  at  3  T  as  opposed  to  1.5  T  for  two  of  the  radiologists  in  the  same  study. 
Specificities were similar for all readers at 1.5 T and 3.0 T.  
Imaging the ankle at 7 T is mainly limited by the lack of commercially available, dedicated ankle 
coils. Thus, one group used an 8-channel head array coil for performing trabecular bone imaging at 
7 T, and found that the relative noise enhancement factor was lower at 7 T than at 3 T for parallel 
imaging acceleration factors higher than three [38,39]. 
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Imaging the wrist: The wrist is an especially challenging region because of the small size of the 
relevant anatomic structures, such as the intrinsic and extrinsic ligaments, the articular cartilage, and 
the Triangular Fibro Cartilage Complex (TFCC). Sensitivity, specificity, and accuracy for imaging the 
TFCC pathology are higher at 3 T than 1.5 T [40]. In addition, trabecular bone imaging has already 
been performed at the wrist using 3 T MR scanners, which resulted in a 16-fold increase in SNR as 
compared to 1.5 T and a maximum spatial resolution of 0.20 × 0.20 × 2.00 mm
3 [41]. 
Farooki et al. were the first to image the wrist above 3 T; they qualitatively compared 1.5 T with 
8 T and concluded that 8 T was superior for the visualization of the infrastructure of the median nerve 
and in the definition of the boundaries of the carpal tunnel [42]. Other authors went on to quantify the 
difference between 1.5 T and 7 T MRI of the wrist and found that SNR was about five times higher in 
tendon,  bone,  muscle,  and  nerve  [43].  These  authors  achieved  a  maximum  spatial  resolution  of 
0.16 × 0.16 × 1.50 mm
3. 
The New York University research group uses an in-house built 8-channel receive and 4-channel 
transmit RF-coil for wrist imaging, which provides the possibility to perform parallel imaging; the 
maximum spatial resolution they achieved in vivo was 0.08 × 0.08 × 2.00 mm
3 [44].  
In summary, morphological MR imaging at 3 T has already been proven to be superior to 1.5 T in 
many  brain  and  musculoskeletal  imaging  applications  and  is  widely  used  in  the  clinical  routine; 
nevertheless, imaging at 3 T continues to improve. At 7 T, initial studies have demonstrated the great 
potential of those systems for ultra-high resolution imaging, but several technical challenges remain to 
be solved. In the future, we hope to be able to fully realize the benefits of high- and ultra-high-field 
imaging  by  combining  ultra-high  resolution  morphological  imaging  with  functional  imaging 
techniques, not only in the brain but also in the small joints of the human body. 
Functional MRI—Techniques and Applications 
During the second half of the last century biology, in particular brain research, became increasingly 
important in the field of psychology. A new scientific discipline evolved—Cognitive Neuroscience. 
The rapid growth of knowledge in this discipline has been tellingly documented already by four books 
entitled “The Cognitive Neurosciences”, edited by Michael Gazzaniga between 1995 and 2009. Two 
dominant approaches, pursuing ultimately the same aim, are manifest in these works: the first begins 
with sub-cellular and cellular processes in order to explain functions of small and finally large scale 
neuronal networks, while the other observes activities of large scale networks during experimentally 
defined behavioural and cognitive challenges, subdividing them into smaller networks to describe their 
interconnectivity and interaction. Both utilize the knowledge gained by the other approach. 
The  latter  strategy  has  been  driven  by  the  development  of  powerful  imaging  techniques,  in 
particular MRI, fMRI, MRS and PET. These ‘sensor-systems’ have added a new dimension to the data 
as gathered previously with more simple methods like electrophysiology, providing highly resolved 
localization of distributed processes. This feature initiated not only the study of whole brain sensory 
systems  but  also  widely  distributed  processing  systems,  that  is  neuronal  networks  that  mediate 
complex mental processes such as language, spatial ability, emotion, empathy, etc.  
The most widely used contrast mechanism in the mapping of brain activation is the so-called BOLD 
(blood-oxygen level dependent) contrast, which is based on blood oxygenation changes in the venous Sensors 2010, 10                        
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vessels and capillaries following electric activity of nerve cells and related metabolic changes [45]. In 
BOLD-based functional MRI, ultra-fast echo-planar imaging (EPI) is the workhorse for functional 
studies. Time-series of rapid whole- or part-brain imaging slabs are recorded during rest and/or task 
performance, technically limited by temporal and spatial resolution, SNR and physiological artifacts. 
Major  artifacts  result  from  intra-voxel  signal  dephasing  [46-48],  voxel  blurring  due  to  broadened 
point-spread function (PSF), physiological artifacts due to breathing and heart-beat, and gross head 
motion. The consequences of these artifacts and the correction schemes which may be applied are 
different in different brain areas as well as being dependent of magnetic field strength and scanner 
performance, leading to the need for specifically optimized measurement protocols (e.g., Robinson, 
Moser and Peper, in [5]). Cortical regions, due to better magnetic homogeneity than subcortial or 
limbic  areas,  are  typically  scanned  with  27–64  mm
3  nominal  resolution,  resulting  in  a  temporal 
resolution (TR) of about 3 s for a 20-slice slab. In studies of emotion, for example, high-resolution EPI 
with ≤10 mm
3 (3 T) or 1 mm
3 (7 T) voxels should be used, however, this may  reduce temporal 
resolution to >5 s or brain coverage (also depending on the gradient system employed). In studies 
where high temporal resolution is required (TR ≥ 100 ms), Brain Activity Movies, or BAM’s [49], 
may be generated. Such rapid acquisition reduces the SNR per unit time, however, as well as the brain 
coverage that may be achieved. Functional connectivity data may be collected during rest/non-activity 
using EPI time series [50]. Spontaneous BOLD-signal fluctuations may indicate resting-state networks 
in  the  brain  [51-53],  and  also  pathological  disturbance  [54].  Image  preprocessing  is  necessary  to 
reduce artifacts (e.g., Weissenbacher et al. [55]) and statistical mapping to either create brain activity 
maps  or  visualize  white  matter  bundles.  Finally,  software  to  co-register  and  map  functional  onto 
anatomical data may be used to help visualize the wealth of information appropriately. 
Research on unconscious visual processes and their capacity to influence human behaviour has a 
long and controversial history within Psychology (see Kouider et al. [56] for a review). An influential 
view in the Cognitive Neurosciences proposes that such unaware processing of stimuli can occur in 
sub-cortical structures without any significant involvement of the cortex, while these processes may in 
turn modulate cortical activity [57]. Other models argue for an essential role of long-distance networks 
linking, e.g., the higher sensory areas and the prefrontal and parietal cortex [58], or link awareness to 
early  activations  within  primary  sensory  areas  or  functionally  specialized  brain  areas  such  as  the 
fusiform face area (FFA) [59]. 
Experimentally,  a  reduction  of  conscious  awareness  can  be  achieved  by  reducing  the  stimulus 
presentation  time  below  the  individual  visual  sensory  threshold.  Such  an  approach  enables  the 
investigation  of  the  modulation  of  brain  activity  induced  by  truly  sub-  (unconscious)  and 
superliminally (conscious) presented neutral stimuli.  
Multi-Modal Integration at High Magnetic Field: MRI, fMRI and Slow Cortical Potentials (SCP) 
Although modern high-field MR scanners offer TRs down to 100 msec, high temporal resolution 
comes at the cost of reduced spatial resolution and/or brain coverage. This fact initiated efforts to  
co-record  fMRI  and  the  electroencephalogram  (EEG)  in  parallel;  the  more  so  because  
electroencephalography has also evolved into a functional brain imaging technique. Algorithms have 
been developed and tuned to estimate sources of brain activity based on scalp potential distributions Sensors 2010, 10                        
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captured  via  multi-channel  EEG  recording,  however,  with  the  restriction  to  activities  within  the 
cerebral cortex [60,61]. Additionally, EEG is certainly closer linked to the neuronal activity since it is 
composed of a sum of neuronal field potentials (albeit a complex one), whereas the BOLD signal 
indirectly mimics neuronal activity via blood oxygen consumption showing an individual but constant 
delay of 3 s to 8 s in the various brain regions. Parallel recording of fMRI and EEG, therefore, enables 
short latency imaging with the aid of the fMRI’s high-resolution localization feature. This way both 
the temporal and spatial course of brain activity can be traced.  
Since the first publication of the simultaneous recording of electroencephalogram (EEG) and BOLD 
contrasted MRI in 1993 [62] great efforts have been made to turn this powerful tool into a standardized 
technique. However, the technical problems arising from the integration of these two techniques are 
manifold  in  terms  of  developing  suitable  amplifiers  and  procedures  to  correct  for  MR  related 
artifacts [63]. While MR-compatible EEG amplifiers are becoming increasingly available, elimination 
of scanner-induced artifacts in the EEG recordings is still challenging. Basically, these artifacts can be 
divided into two groups: (1) artifacts related to the cardiac pulse, which causes movements of the 
electrodes within the static magnetic field (B0) of the MR-scanner [64] and (2) artefacts produced by 
the fast switching of the B0-gradients [65]. For event-related potentials (ERP), the efficacy of several 
software algorithms in the compensation of these artifacts has been shown repeatedly (for a review see 
Ritter  &  Villringer [66])  allowing  the  method  to  become  an  essential  tool  in  the  investigation  of 
neuronal correlates of cognitive functions [63]. 
Slow cortical potentials (SCP), however, form a special class of ERPs that accompany temporally 
extended (up to 10–20 s) sensory/cognitive processes. Unlike the regular ERPs, SCPs neither show 
specific peaks nor a well-structured temporal course but are comprised of spatially and temporally 
extended  waveforms  in  the  frequency  range  far  below  1  Hz—therefore  also  referred  to  as  
direct-current EEG (DC-EEG). While the neural origin of these potential changes is the same as that of 
ERPs, they are also tightly related to post-synaptic potentials (PSPs), but possibly not only generated 
by  a  superposition  of  many  short-living  PSPs,  but  also  of  long-lasting  PSPs.  Furthermore, 
contributions  of  astroglia-depolarizations  possibly  induced  by  neuron-glia  communication  [67,68] 
have been shown. Although a complete and coherent view of the neural basis of SCPs is missing, work 
on  animal  models  has  shown  a  tight  correlation  between  the  fMRI  BOLD  signal  and  local  field 
potentials measured extracellularly within the cortex (for a review see Logothetis [69]). In humans, 
this relationship has been shown by Lamm et al. [70] and Khader et al. [71], using spatial imagery 
tasks, and by He et al. [72] studying spontaneous fluctuations of the BOLD signal.  
The  studies  cited  above  suggest  a  tight  relationship  between  SCP-variations  and  the  BOLD 
response. However, these studies did not record both signals simultaneously. fMRI and EEG data were 
acquired separately since: (1) MR-compatible EEG amplifiers capable of recording DC-EEG were not 
available until recently, and (2), because existing scanner-artifact reduction methods would fail for 
SCPs since they would suppress the DC component of the EEG-signal. In the Results section we 
present  an  approach  where  NeuroConn  Inc.  (Ilmenau,  Germany),  in  close  collaboration  with  the 
University  of  Vienna  and  the  Medical  University  of  Vienna,  developed  an  adequate  artifact 
compensation procedure for simultaneous SCP and fMRI data acquisition.  
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Advanced Functional 
23Na-Imaging of Articular Cartilage 
Articular cartilage consists mainly of an extracellular matrix made of type II collagen, proteoglycan, 
chondrocytes,  and water [73]. Proteoglycan (PG) is made of a linear protein core to which many 
glycoproteins  known  as  glycosaminoglycans  (GAG)  [74]  are  attached.  Proteoglycan  serves  to  
cross-link  the  collagen  fibrils  in  the  extracellular  matrix  to  provide  both  compressive  and  tensile 
strength to the matrix. In addition, the proteoglycan links restrict fluid flow through the matrix and 
thereby increase resistance to structural deformation.  
The sulfate and carboxyl groups of the glycosaminoglycans impart a negative fixed charge density 
(FCD) to the matrix. These negative ions attract positive counter-ions (sodium) and water molecules 
and  provide  a  strong  electrostatic  repulsive  force  between  the  proteoglycans.  These  osmotic  and 
electrostatic forces are responsible for the swelling pressure of cartilage. The configuration of the PG 
macromolecules also contributes to the resistance of the matrix to the passage of water molecules and 
hence affects the mechanics of the cartilage in this fashion. 
The  onset  of  osteoarthritis  (OA)  is  understood  to  be  associated  primarily  with  biochemical 
phenomena. The ability to quantify these molecular changes using novel sensors will provide a tool for 
the  early  diagnosis  of  osteoarthritis  and  treatment  monitoring.  The  loss  of  proteoglycan  from  the 
extracellular matrix has been hypothesized to be the event that initiates the onset of OA [75,76]. 
The  loss  of  proteoglycan  with  the  onset  of  OA  results  in  a  reduction  of  FCD  in  cartilage. 
Maroudas et al. have shown that the fixed charge density (FCD) of cartilage is correlated to the GAG 
content of cartilage [77]. Since the FCD is counter-balanced by the Na ions, loss of PG (hence GAG 
and FCD) due to cartilage degeneration results in the loss of sodium ions from the tissue. The loss of 
the  negatively  charged  PG  lowers  the  FCD  in  the  tissue,  thereby  releasing  positively  charged  
sodium ions.  
Sodium (
23Na) MR imaging has been validated as a quantitative method of computing FCD and, 
hence, proteoglycan content, in healthy humans [78-80]. Healthy human cartilage FCD ranges from a 
concentration  of  50  mM  to  250  mM,  depending  on  the  age  and  location  in  the  tissue  [81].  As 
demonstrated in controlled cartilage degradation experiments [78,82], the sensitivity of sodium MR 
imaging is adequate for detecting small changes in proteoglycan content on the order of 5%. Sodium 
MRI experiments were performed on the knee cartilage of healthy as well as early stage OA patients at 
4 T and demonstrated the feasibility of sodium MRI in computing PG loss in early stage OA. [79] 
The major advantage of 
23Na MRI, especially of cartilage, is that it is highly specific to PG content 
and, since the sodium from surrounding structures in the joint is low (<50 mM), cartilage can be 
visualized with very high contrast without the requirement for any exogenous contrast agent such as 
that in dGEMRIC [83]. It can be used to quantify early molecular changes in osteoarthritis. 
The disadvantage of sodium MRI is that it requires field strengths of >3 T to obtain quality sodium 
images that enable accurate quantification of cartilage FCD. Furthermore, due to the limitations of 
gradient strengths and other hardware requirements, most of the sodium imaging experiments reviewed 
here employed echo times of >2 ms. Since the fast T2 decay of cartilage lies in the range 1–2 ms, 
substantial signal is lost before the acquisition. This is a major contributor to the low SNR of sodium 
compared  with  conventional  proton  MRI.  Additionally,  the  sodium  gyromagnetic  ratio  (γ)  is  
one-quarter that of protons, meaning that sodium MRI requires four times stronger gradients to obtain Sensors 2010, 10                        
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images with the same resolution to that of proton MRI. Resolution, however, is not only a function of 
the gyromagnetic ratio but also of the receiver bandwidth. The MR sensitivity for 
23Na is only 9.2% of 
that of protons (
1H), and the in vivo concentration is ~360 times lower than the in vivo water proton 
concentration.  The  combination  of  these  factors  results  in  a 
23Na  signal  which  is 
approximately 4000 times smaller than the 
1H signal. 
In Vivo Magnetic Resonance Spectroscopy 
Multi-nuclear  magnetic  resonance  spectroscopy  (MRS)  is  a  non-invasive  tool  for  investigating 
metabolism in vivo. Its applications range from investigation of normal physiology in healthy humans 
and  studying  metabolic  changes  under  the  influence  of  ageing,  exercise,  nutrition  or  
medication [84-87] to the diagnosis of a wide range of diseases which include, but are not limited to, 
metabolic  and  neurological  disorders  (e.g.,  diabetes,  myopathies,  Parkinson’s  disease,  epilepsy), 
psychiatric disorders, and many forms of cancer (e.g., in the brain, breast or prostate) [88-90]. In vivo 
magnetic resonance is most commonly associated with its use as an imaging modality for clinical 
diagnostics (MRI, see previous sections).  
MRS is based on the same physical principle as MRI and can be performed on the same equipment; 
however an additional component of information is obtained from the tissue under investigation: the 
chemical environment, i.e., which molecule or functional group the observed nuclei is surrounded by, 
can  be  distinguished  via  a  shift  in  resonance  frequency  caused  by  the  molecules’  electron 
configuration, which leads to shielding of the magnetic field. Additionally, spatial information can be 
retained to various extents, from no specific localization information, beyond the radio frequency (RF) 
coil’s position for signal detection, through one dimensional and single voxel localization up to full 3D 
chemical shift imaging, capable of generating a map of spectra for each point on a three dimensional 
grid. Of course, the choice of methods is governed by a trade-off between sensitivity, temporal and 
spatial  resolution  (both  influencing  specificity)  and  total  measurement  time,  limited  by  motion 
artifacts,  patient  compliance  and  potentially  also  availability  of  the  scanner.  Using 
1H  MRS  it  is 
possible  to  quantify  total  creatine,  trimethylammonium  (TMA)  compounds,  intra-  and 
extramyocellular lipids (IMCL/EMCL) in muscle, involved in the pathogenesis of insulin resistance 
and  type-2  diabetes [91,92].  The  metabolites  N-acetylaspartate  (NAA),  creatine,  choline,  inositol, 
glutamine, glutamate, γ-aminobutyric acid (GABA), lactate and others are accessible when 
1H MRS is 
applied to brain [93-97], rendering the method valuable in the study of physiological metabolism and 
pathologies,  as  the  metabolites’  concentrations,  typically  abundant  in  the  millimolar  range,  
change [90-100]. 
MRS is not limited to the hydrogen nucleus. Other physiologically relevant nuclei may be measured 
by  transmitting  the  RF  pulses  with  a  frequency  specific  to  the  particular  nucleus.  This  requires 
dedicated antennas (RF coils) specifically designed to match the resonance frequency of the nucleus 
and the given magnetic field strength B0. This offers a wider view on the metabolism and state of tissue 
under investigation, as either a different set of metabolites can be observed or molecular properties 
(e.g.,  binding  to  cell  walls,  orientation  effects)  are  exploited  to  obtain  specific  information.  
Multi-nuclear MRS is most frequently employed using the phosphorus (
31P) or carbon (
13C) nuclei. 
Phosphorus is of physiological interest as high-energy phosphates play an important role in metabolic Sensors 2010, 10                        
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turnover and can be detected directly [84]. In particular, adenosine triphosphate (ATP) turnover and 
proton  handling  can  be  studied  by 
31P  MRS  of  muscle [101,102],  rate  constants  of  changes  in  
phospho-creatine  (PCr)  concentration  during  exercise [103]  and,  especially,  recovery  from 
exercise [101,104]  can  teach  us  about  mitochondrial  function  and  oxidative  ATP  
re-synthesis [105,106]. As has been shown recently, a combination of different multi-nuclear MRS 
methods can further increase their value beyond the sum of their respective contributions by adding 
complementary  information  to  a  view  on  metabolism  not  accessible  to  each  of  the  methods 
alone [85,107,108]. 
Magnetic  resonance  at  ultra-high  field  strength  has  many  advantages,  particularly  for  MR 
spectroscopy [1,2,109]: firstly, the signal intensity, which is often the key factor for the feasibility of a 
spectroscopy  study,  increases  with  field  strength  and  secondly,  the  chemical  shift  dispersion,  i.e., 
separation of the signal components which are attributed to the different metabolites to be quantified, 
obeys a linear relationship with field strength. This stronger separation makes the identification of 
resonances easier, more reliable or even possible at all, as signals of individual metabolites may not be 
adequately resolved at lower field strength. Additionally, the attraction of ultra-high field MRS is 
enhanced  by  the  reduction  of  T1  relaxation  times  for  certain  metabolites  (e.g.,  phospho-
creatine) [110,111], allowing shorter repetition times and thus a further increase in signal-to-noise ratio 
(SNR) by averaging measurements, increasing time resolution or reducing total measurement time. 
To  fully  exploit  the  advantages  of  increased  magnetic  field  strength  some  technical  challenges 
inherent to the MR physics in this regime need to be addressed: 
•  Higher  demands  on  RF  power,  due  to  the  higher  resonance  frequency,  leads  to  increased 
specific absorption rate (SAR).  
•  Susceptibility effects increase with field strength, leading to broadening of peaks in spectra. 
Thus, MRS at higher field makes higher demands on shimming, (i.e., the optimization of the 
local field homogeneity).  
•  The  increased  spectral  dispersion  at  higher  fields  also  requires  correspondingly  increased 
bandwidths of radio frequency pulses. This can be accomplished by shortening the pulse length 
while increasing the amplitude of the transmitted radio frequency’s magnetic field component. 
This in turn increases SAR and may lead to exceeding the maximum voltage which can be 
applied to the RF transmit coil.  
•  The  nuclear  resonant  frequency  increases  linearly  with  static  field  strength,  shortening  the 
wavelength  of  applied  RF  pulses.  This  in  turn  gives  rise  to  a  highly  inhomogeneous  RF 
excitation. 
2. Results and Discussion 
Typical parameter settings for 3 T and 7 T protocols, based on our current experience on Siemens 
MR-systems, are described in the Experimental Section and exemplary results are shown below for 
various human organs, including brain, joints and cartilage.  Sensors 2010, 10                        
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2.1. High-Resolution Structural MRI 
Examples for high-resolution structural MRI of the brain are given in Figure 1. These images where 
acquired on a healthy volunteer and demonstrate T1 and T2 weighted contrast. Note the strong contrast 
between gray and white matter in the T1 weighted image as well as the excellent contrast between CSF 
and brain tissue in the T2 weighted image.  
 
Figure 1. Comparison of T1 and T2 contrast at 3 T (12-channel head coil): T1-weighted, 
transverse slice through the brain (left). As can be seen T1-weighted images provide an 
excellent contrast between gray and white matter (black arrow) as well as a good definition 
of the ventricles. On the right side the same slice with T2-weighted contrast is shown; note 
the lower gray and white matter contrast but the excellent definition of the ventricles (white 
arrow). 
 
 
An example of susceptibility-weighted contrast in the human brain at 7 T is given in Figure 2. Note 
the excellent definition of veins, due to deoxygenated blood, as well as the good delineation of the 
basal ganglia, due to higher iron content.  
Examples for high-resolution structural MRI of the knee and cartilage are given in Figure 3. A 
dedicated knee-coil was used to visualize details in cartilage and menisci. In addition to structural 
proton  imaging,  we  have  recently  applied  sodium  imaging  in  patients  after  matrix-associated 
autologous cartilage transplantation (MACT). The resolution achieved was sufficient to visualize even 
the thin cartilage layer adjacent to the proximal tibio-fibular joint (Figure 4). In our patient group 
sodium imaging allowed to differentiate between different concentrations of sodium and hence GAG 
in different portions within the transplants which underscores its strength in the overall evaluation of 
cartilage transplants in contrast to the limited biopsy sample evaluation. We found a good correlation 
between sodium imaging and dGEMRIC in the quantification of the GAG concentration in patients 
after MACT [112].  Sensors 2010, 10                        
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Figure  2.  Susceptibility-Weighted  Imaging  at  7  T  (8-channel  head  coil);  this  image 
represents a minimum intensity projection over a 6 mm slab. Note that both, veins and iron 
containing structures like the basal ganglia appear hypo intense. This image was acquired 
using an echo time of 15 ms and a resolution of 0.3 × 0.3 × 1.2 mm. 
 
Figure 3. 7 Tesla gradient-echo image of the knee joint in the coronal plane. The cartilage 
layers and the menisci are shown in high resolution and exquisite detail and will help to 
detect even subtle pathologies of these structures. Additionally, the trabecular structure of 
the bones is shown in ultra-high resolution, which may promote osteoporosis research. 
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Figure 4. The 7 Tesla sodium image in the sagittal plane shows cartilage with high sodium 
content in the lateral femoral tibial joint cavity of the knee joint. Since sodium content 
correlates with the proteoglycan content of cartilage, which is related to the biomechanical 
properties of cartilage, a sodium image of cartilage provides biomechanical information. 
Note that even the thin cartilage layers of the proximal tibio-fibular joint are shown with 
sodium imaging. 
 
2.2. Functional MRI 
In this particular study healthy subjects were examined while performing a forced choice detection 
task. The subjects’ task was to identify black/white target faces, which were sequentially embedded 
within two pictures of equiluminiscent white noise. Targets were randomly chosen images from six 
equiluminiscent faces of men and women. Following each presentation, subjects were requested to rate 
if they were able to identify the faces’ gender, saw a face but could not rate the gender, or had not seen 
any presentation at all. Presentation durations were adjusted to three subliminal and three superliminal 
values according to the subjects’ individual visual sensory thresholds, and were presented 12 times 
each in randomized order. Individual thresholds were determined before fMRI scanning at 7 T. For 
each subject the percentage of correct detections per duration was calculated and finally a logistic 
curve fitted across all durations. Individual thresholds were defined as that duration which resulted in 
50  percent  correct  recognitions.  Exact  timing  of  the  presentations  was  provided  by  a  custom  
build  LC-shutter  tachistoscope  [113].  For  single  subject  analyses  statistical  parametric  maps  were 
calculated using the general linear model with both regressors corresponding to the six presentation 
durations as well as sigmoidal regressors corresponding to the probability with which the faces’ gender 
was detected. This approach enabled on the one hand identification of those neuronal regions that were 
activated by the different presentation durations (Figure 5) and on the other hand identification of those 
brain areas that were involved in subjective perception (Figure 6). As expected, neuronal areas related 
to the different presentation durations were the thalamus and the primary visual cortex and areas that Sensors 2010, 10                        
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followed the perception curve were within the prefrontal and the cingulate cortex, additionally to the 
predominantly sensory areas. 
Figure  5.  Brain  regions  that  are  activated  by  the  different,  ultra-short  presentation 
durations using a linear regressor comprising the presentation durations of 1, 3, 5, 7, 9, and 
11  ms.  The  sagittal  map  shows  significant  BOLD-signal  increases  projected  onto  the 
anatomical brain image of the subject (p < 0.05 FWE-corrected). 
 
Figure 6. Activations associated with subjective perception. For this analysis a sigmoidal 
regressor  corresponding  to  the  probability  with  which  the  faces'  gender  was  detected  
(A) was used. The sagittal map (B) shows significant BOLD-signal increases projected 
onto the anatomical brain image of the particular subject (p < 0.05 FWE-corrected). 
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Figure 6. Cont. 
 
(B) 
 
Understanding the neuronal correlates of consciousness is one of the most challenging problems 
within  the  Cognitive  Neurosciences.  As  mentioned  above,  probing  stimuli  around  their 
sensory/perceptual thresholds is one way to identify brain structures that are essential for conscious 
experience. However, responses to stimuli presented for these short durations are weak and so is their 
BOLD response. In such applications the high sensitivity of a 7 T MR scanner is quite advantageous as 
can be seen from preliminary results presented here. 
The brain areas identified with the two analysis approaches employed are in line with the so-called 
global  neuronal  workspace  model  [58].  Central  to  this  theory  is  the  hypothesis  that  two  clearly 
distinguishable hierarchy levels can be described within the functional and anatomical architecture of 
the brain. The first level includes cortical and subcortical areas responsible for specific tasks within a 
certain sensory modality. According to the Dehaene model these areas are activated automatically and 
therefore work mostly unconscious. The primary visual cortex and the thalamus may be seen as part of 
this level since their activity linearly increased with presentation duration. The second level consists of 
prefrontal, cingulate, and parietal cortices and is characterised by many widespread connections to 
other  areas  within  the  brain.  This  high  interconnectivity  allows  for  fast  and  flexible  exchange  of 
information between the different sensory modules, a prerequisite for awareness. Additional activities 
within the prefrontal and cingulate cortex, as shown by the second analysis, confirms this view. 
2.3. Multi-Modal Integration of MRI, fMRI, and Slow Cortical Potentials (SCP, DC-EEG) 
In order to demonstrate the feasibility of simultaneous EEG and fMRI data acquisition a simple 
experiment  using  visual  stimulation  will  be  presented.  As  stimulus  a  slowly  rotating  
checkerboard-propeller was presented in the center of the visual field for 8 s. Stimuli were repeated 40 
times with a fixed 7 s black screen inter-stimulus interval in two runs, with and without parallel fMRI 
acquisition. EEG was recorded via 61 silver/silver chloride scalp electrodes using a NEURO PRAX® 
MR full-band EEG ampliﬁer (NeuroConn Inc., Ilmenau, Germany). For offline eye movement artifact 
correction vertical and horizontal electrooculograms were recorded bipolarly from above and below Sensors 2010, 10                        
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the left eye and from the left and right outer canthi. The subject’s skin was slightly scratched at all 
recording sites in order to minimize skin potential artifacts and to ascertain homogeneous electrode 
impedance.  The  electrodes  were  filled  with  degassed  electrode  gel  (Electro-Gel,  ElectrodeCap 
International Inc., Eaton/OH, USA) to prevent ultra-slow baseline shifts [114]. Gradient and pulse 
artifacts were suppressed on-line using an adaptive template-matching algorithm. To this end up to 100 
channel-specific  templates  were  generated  in  a  previous  acquisition  run  [115].  Thereafter  eye 
movement  artefacts  were  eliminated  using  a  linear  regression  approach  with  channel-specific 
correction coefficients [116]. Finally, single trial signals were low-pass ﬁltered at 8 Hz and averaged. 
In  order  to  identify  the  cortical  structures  involved,  the  resulting  SCPs  were  subjected  to  current 
density analyses using sLoreta [61]. 
Figure 7. Averaged waveforms at representative scalp locations (left and middle row) and 
scalp potential topographies (right; dark blue color indicates stronger activation) averaged 
across  the  interval  from  2,000–5,000  ms  post  stimulus  of  a  single  subject.  (a)  SCPs 
recorded inside the scanner without fMRI acquisition, (b) SCPs recorded while acquiring 
fMRI data. 
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MR-images were acquired on a 3 Tesla TIM Trio system. For single subject analysis statistical 
parametric maps were calculated using the general linear model with regressors corresponding to the 
visual  stimulation  onsets.  Activity  in  occipital  areas  was  found  in  the  SCP  recordings  of  both 
acquisition  runs  (see  Figure  7).  A  clear  negative  going  SCP  can  easily  be  identified  at  occipital 
recording  sites,  which  is  slightly  smaller  during  fMRI  acquisition.  As  expected  this  waveform  is 
restricted to sensory visual areas, i.e., to parietal and occipital recording sites, which can also be seen 
in the corresponding topographic potential pattern (color coded in blue). SCP based source localization 
(Figure 8) revealed strong activation in and around the primary visual cortex. The corresponding fMRI 
results showed activation primarily in the middle occipital gyrus (Figure 9). 
The  experiment  presented  resulted  in  SCP  waveforms,  topographies,  and  source  localizations, 
comparable  to  data  acquired  outside  the  MR  scanner.  These  results  clearly  demonstrate  that 
simultaneous acquisition of DC-EEG and fMRI data, i.e., data acquired by means of different sensor 
systems  within  one  experiment  covering  different  aspects  of  brain  activity,  is  feasible  at  high  
magnetic fields. 
Figure 8. SCP-based source localization within the interval 2,000—5,000 ms post stimulus 
of  a  single  subject.  (a)  SCPs  recorded  inside  the  scanner  without  fMRI  acquisition,  
(b) SCPs recorded while acquiring fMRI data. 
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Figure 9. Single-subject fMRI results of the visual stimulation paradigm as used in Figures 
7b and 8b (p < 0.001, uncorr.). 
 
2.4. Magnetic Resonance Spectroscopy 
For  an  illustration  of  ultra-high  field  MRS  applied  to  human  skeletal  muscle  see  Figure  10. 
Localized 
1H spectra were acquired from human soleus muscle, at 3 and 7 Tesla, using a STEAM 
(“stimulated echo acquisition mode”) singel voxel localization scheme with an echo time TE = 20 ms 
and  a  voxel  size  of  approx.  2 mL,  in  MR  systems  from  the  same  manufacturer  (Tim  Trio  and 
Magnetom 7 T, both by Siemens Medical Solutions, Erlangen, Germany). Parameters at 3 Tesla were 
TE = 20 ms, TM = 30 ms, TR = 4 s, VOI = 12 × 12 × 12 mm, 32 averages. At 7 Tesla, measurement 
parameters were TE = 20 ms, TM = 10 ms, TR = 1.5 s, VOI = 12 × 12 × 20 mm, 32 averages. Proton (
1H) 
MR  spectra  of  skeletal  muscle  allow  quantification  of  e.g.,  total  creatine,  trimethylammonium 
compounds  and  lipids.  Due  to  a  bulk  magnetic  susceptibility  effect,  it  is  possible  to  distinguish 
between intra- and extracellular lipids, which becomes more pronounced at 7 Tesla. Several further 
advantages of ultra-high field strength, as compared to spectra acquired at 3 Tesla, become evident 
from the example given in Figure 10. As chemical shift dispersion increases linearly with B0, the 
separation of resonances improves (e.g., between TMA and creatine), provided that macroscopic field 
inhomogeneities can be compensated using high order shim routines. Signal-to-noise ratio is increased Sensors 2010, 10                        
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at higher field, improving reliability of quantification, for example the signal attributed to the CH2 
group of creatine (Cr2) is clearly visible at 7 T. 
Figure 10. 1H spectra of skeletal muscle acquired at 3 T (a) and 7 T (b), demonstrating 
improvement of spectral quality with increasing B0 field strength. Advantages of higher B0 
field strength are improved separation of resonances and higher signal to noise ratio (b). 
 
(a) 
 
(b) 
 
Another example of ultra-high field MRS is shown in Figure 11. Dynamic localised 
31P spectra of 
skeletal muscle were acquired on a 3 T whole body scanner (Bruker Biospin, Ettlingen, Germany) and 
a  7 T  system  (Siemens  Medical  Solutions,  Erlangen,  Germany).  Signal  gain  at  7  Tesla—further 
improved  here  by  using  an  advanced  acquisition  method  which  was  recently  implemented  on  the 
Siemens platform (
31P semi-LASER, “localization by adiabatic selective refocusing” [104,117])—was 
utilized to achieve higher temporal resolution by avoiding averaging of consecutively acquired spectra. 
In  exercising  muscle,  phosphocreatine  is  depleted  under  concomitant  accumulation  of  inorganic 
phosphate. During recovery, PCr is resynthetised via oxidative phosphorylation, with a time constant 
typically  on  the  order  of  minutes.  These  processes  can  be  followed  by  dynamic 
31P  MRS. Sensors 2010, 10                        
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Measurements  at  3  Tesla  were  performed  with  STEAM  (TE  =  7.5 ms,  TM  =  30 ms,  TR  =  7.6 s, 
1024 complex data points per acquisition). At 7 Tesla, semi-LASER was used (TE = 53 ms, TR = 8 s, 
2048 complex data points). The quality of 7 T data shown for each time point surpasses the quality of 
measurements at 3 T, so that no averaging was necessary at all for quantifying PCr in the 7 T spectra 
using a time domain fit routine for MR spectra. Reliable quantification of phosphocreatine (PCr) and 
inorganic phosphate [87] time courses during and after aerobic exercise of human muscle [84], from 
localized 
31P spectra is thus possible with higher temporal resolution at 7 T. This allows determination 
of  PCr  resynthesis  kinetics,  a  measure  for  oxidative  capacity  of  skeletal  muscle,  with  
improved specificity. 
Figure 11. Dynamic localized 31P MRS of skeletal muscle acquired at 3 Tesla (left) and 
7 Tesla (right). Signal gain at 7 T (in connection with an improved acquisition method, 31P 
semi-LASER)  allows  higher  time  resolution  and  yet  surpasses  spectral  quality  for 
quantification  of  creatine  phosphate  (PCr)  and  inorganic  phosphate [87]  time  courses 
during and after aerobic exercise of human muscle, compared to a similar measurement at 
3 T. Spectra were scaled to equal noise level. 
 
3. Experimental Section 
Here  we  briefly  describe  hardware  and  software  requirements  and  parameters  needed  to  run 
morphological, functional and metabolic MR-measurements and how to process the data. Basically, we 
need  to  modify  the  magnetic  environment  of  the  body  and  body  molecules  using  a  strong,  static 
magnetic field and weak ‘gradient’ magnetic fields. The typical range  of static magnetic fields in 
clinical systems is 0.2 T to 3.0 T (Figure 12); for human studies between 4 T and 9.4 T only research 
systems are available (Figure 13). Gradient coils typically produce relatively weak linear, orthogonal 
magnetic fields gradients of up to about 40 mT/m for the whole body or up to 100 mT/m for the head. 
Furthermore, adapted physical sensors (RF coils; see figures 12 and 13) are required to actually excite 
the nuclear spins in biomolecules (using a circular polarized magnetic field) in the region-of-interest Sensors 2010, 10                        
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(e.g., the brain), and detect weak RF signals from the tissue. Depending on the particular hardware 
used (i.e., magnetic field strength, nucleus/resonance frequency chosen, gradient strength, duration and 
timing  of  RF-excitation  pulses,  etc.)  a  computer  will  create  an  image  or  spectrum  of  the  signals 
detected [118]. Typically, these raw data will be processed to further reduce artifacts originating from 
physiological motion (e.g., from breathing, heart beat, gross body motion, susceptibility, flow, etc.), 
reconstructed again and either visually diagnosed or further processed using dedicated software and 
statistics.  Contrast  in  the  images  obtained  and  used  for  diagnostic  purpose  is  either  native  (i.e., 
optimized  via  MR  parameter  settings)  or  enhanced  via  specific  contrast  agents  (i.e.,  by  locally 
manipulating  the  magnetic  environment  using  chemical  sensors,  e.g.,  chelates  of  gadolinium  or  
iron particles).  
Figure 12. High field whole body MR scanner Siemens TIM Trio (3 Tesla, left) with a  
12-channel receive-only head coil (Siemens). A cylindrically polarized (CP) whole body 
RF coil for transmitting 123 MHz (1H at 3 T) radio frequency signals and B0 gradient coils 
are installed in the scanner bore. Various Rx or local Tx/Rx coils can be used, e.g., a  
32-channel receive head coil also by Siemens (right). 
 
 
The wavelength of applied RF pulses is reduced at higher field strength and in biological tissue 
(compared to air or vacuum) by its high relative permittivity, producing a proton resonant wavelength 
of approximately 12 cm inside the human body at 7 T. This is smaller than the dimensions of a typical 
organ (human head, thigh or abdomen), giving rise to strong interference within the sample, producing 
a  highly  inhomogeneous  RF  excitation [119-121].  The  responsible  effects  are  wavelength 
interference [121] and attenuation of RF amplitude by tissue conductivity [122]. Two main approaches 
to reducing this inhomogeneity have been proposed: RF shimming [123] and parallel transmission 
(pTx) [124-127], both of which rely on specific RF coil design and hardware extensions to the scanner. 
A full parallel Tx system enables transmission of completely independent RF pulse envelopes on all 
channels, while only amplitude and phase control is required for RF shimming. The RF excitation coils 
used for pTx consist of multiple independent transmission elements (typically 8 or 16), which have 
unique spatial profiles. These profiles may be modulated and superimposed to tailor the magnitude and Sensors 2010, 10                        
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phase of the excited magnetization [128] in the desired volume. Specific absorption rate varies by 
orders of magnitude, locally and on average, depending on the pattern of excitation. To ensure safety 
compliance, the complex behavior of power distribution needs to be validated in numerical models, 
accounting for target patterns and corresponding pTx pulses [124]. 
Figure  13.  Ultra-high  field  whole  body  MR  scanner  Siemens  Magnetom  7  T  (left)  
with 24-channel (transmit-) receive coil (by Nova Medical) placed on the patient bed. B0 
gradient-coils are installed in the scanner bore. The 24-channel Rx head coil (top right) is 
equipped with a transmit coil (outer cylinder), tuned to 300 MHz (Larmor frequency of 1H 
at 7 T). Single-loop transmit/receive surface coil by RAPID Biomedical (bottom right). 
 
 
Safety considerations: As a diagnostic technique based on non-ionizing radiation, magnetic resonance 
imaging and spectroscopy can be considered a low risk procedure, as long as several safety-relevant 
parameters are monitored and kept within certain limits. Three main potential sources of hazards are 
connected with the use of magnetic resonance systems: (1) The radio frequency (RF) field, B1, required 
to tilt the magnetization vector from its equilibrium value and thereby induce a signal which can be 
measured,  causes  energy  deposition  in  the  tissue,  (2)  rapidly  switched  B0  field  gradients,  mainly 
applied for the purpose of encoding spatial information the MR signal, may lead to the induction of 
voltages in tissue, potentially causing nerve stimulation, and finally (3) the static magnetic field B0 
poses a source of risks, predominantly due to the strong attraction forces on ferromagnetic objects. The 
potentially hazardous effects connected with in vivo magnetic resonance are subject to legal limits and 
recommendations issued by national and international organizations. Particularly, the United States 
Food  and  Drug  Administration  (FDA),  the  International  Commission  on  non-ionizing  Radiation 
Protection (ICNIRP), and the International Electrotechnical Commission (IEC) publish standards and 
guidelines  defining  limits  of  applicable  RF-energy,  the  so-called  specific  absorption  rate  (SAR), 
magnetic gradient amplitudes and switching times and B0 field strength. Regulations limit the specific 
power  absorption  and/or  resulting  temperature  increase  [129]  and  define  distinct  thresholds  for Sensors 2010, 10                        
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acceptable  deposition,  depending  on  the  parts  of  the  human  body  investigated.  Limits  distinguish 
between total average and average per gram of tissue in the head, abdomen and extremities, as well as 
averages on various time scales (typically over 5 or 6 min or short term averages of several seconds). It 
can be shown that the deposited power is proportional to the square of the static magnetic field B0
2 and 
to the square of the irradiating RF field B1
2 [130,131]. The calculation of the deposited energy  is 
complex [122] due to the geometrical distribution pattern of B1 in biological tissue, particularly at high 
field strengths, where the wavelength of the RF wave in tissue is on the order of (or smaller than) the 
dimensions of the organs. 
Technical Details on MRI Protocols: 
 
Structural brain imaging: 
   
  MP-RAGE  parameters  at  3  T:  TR/TI/TE  =  2,300/900/3.59  ms,  image-matrix  =  320  ×  320, 
208 sagittal slices, GRAPPA factor = 2, resulting in an isotropic resolution of 0.8 mm, and scan 
time: 12.18 minutes., 
  MP-RAGE  parameters  at  7  T:  TR/TI/TE  =  4,660/1700/4  ms,  image-matrix  =  320  ×  320, 
228 sagittal slices, GRAPPA factor = 2, resulting in an isotropic resolution of 0.65 mm, and scan 
time: 12.50 minutes. 
  TSE parameters at 3 T: 2D-Turbo Spin Echo (TSE), GRAPPA factor = 2, TR/TE = 13,070/92 ms, 
MA = 256 × 256, slices = 128, resulting in a resolution of 1 × 1 × 1.2 mm, and scan time of 
5.15 minutes. 
  Advanced  cartilage  imaging  at  7  T:  PD_FSE;  TR  =  2,400  ms,  TE  =  24  ms,  36  slices, 
FOV = 120 cm
2, Matrix = 1024 × 1024, slice thickness: 2 mm, scan time: 6min37sec. 
  SWI parameters at 3 T: A three-dimensional, fully first-order flow-compensated GE sequence 
with a TE of 29 ms; TR = 36 ms; image-matrix = 320 × 320 pixel; slices = 104; parallel imaging 
(GRAPPA) factor = 2; resolution = 0.64 × 0.64 × 1.3 mm. 
  SWI  parameters  at  7  T:  SWI  sequence;  TE  =  15  ms;  repetition  time  =  28  ms;  
image-matrix = 704 × 528  pixel;  slices  =  96;  parallel  imaging  (GRAPPA)  factor  =  2;  scan 
time = 9.48 min; resolution = 0.3 × 0.3 × 1.2 mm
3. 
 
Functional brain imaging: 
   
  FMRI-EPI parameters at 3 T: single-shot gradient-recalled echo-planar imaging; 12 axial slices 
(4 mm  thickness,  3  mm  gap)  aligned  to  the  connection  line  between  anterior  and  posterior 
commissure; matrix size = 64 × 96; FOV = 210 × 210 mm
2, and TE/TR = 42/1,000 ms. 
  FMRI-EPI parameters at 7 T: single-shot gradient-recalled echo-planar imaging; 4 axial slices 
(5 mm thickness), aligned to include the thalamus and the fusiform gyrus, matrix size = 128 × 128; 
FOV = 240 × 240 mm
2, and TE/TR = 26/200 ms. 
 
23Na-MRI  parameters  at  7  T:  Modified  3D-GRE  sequence:  TR/TE  =  10.0/3.77  ms; 
FOV = 199 × 199  mm
2,  48  slices;  MA  =  64  ×  128;  resulting  in  a  resolution  of 
3.11 × 1.55 × 3.0 mm
3, and scan time of 30:45 min. Sensors 2010, 10                        
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4. Conclusions 
The major advantage of modern sensor technology, including higher magnetic fields, multi-array 
transmit and receive coils, measurement techniques and contrast agents, is the essential shift from 
morphological  to  biochemical  and  metabolic  imaging  techniques,  which  typically  suffer  from  low 
sensitivity at standard field strength (1.5 T). The high signal-to-noise ratio provided by the higher field 
systems, combined with novel sensors provides biochemical and metabolic imaging in reasonable scan 
times, which promotes its widespread clinical application. As a rule of thumb one could argue that all 
measurement techniques limited by SNR, but not SAR, at 1.5 T or 3 T should perform better at higher 
magnetic fields. This includes high-resolution 3D-MRI of small structures, high-resolution fMRI, and 
localized 31P-MRS techniques. On the other hand, there is no need to transfer methods which are 
already limited by SAR and which are clinically useful at 1.5 T or 3 T to higher fields. This is not to 
say that no particular contrast mechanisms and novel approaches may be developed especially at very 
high  fields  and  may  find  also  clinical  use.  For  MR  methods  in  which  the  underlying  contrast 
mechanism does not depend on magnetic field strength, such as water diffusion or gadolinium based 
contrast agents, no substantial gain can be expected except from a general increase in SNR. Finally it 
will  be  the  best  possible  combination  of  organ  size  and  location,  tissue  of  interest  structure  and 
pathology,  Tx/Rx  coil  sensitivity  and  homogeneity,  contrast  mechanism,  image  protocol  and  data 
processing strategy employed which will provide the best data quality available in a given time. In 
addition, artifact reduction during preprocessing and appropriate modeling during post-processing may 
further enhance diagnostic quality. This development would, for example, allow a shift towards a 
diagnosis of diseases in their earliest stages such as osteoarthritis and degenerative disc disease, for 
instance, before severe morphological changes in proton-MRI occur. Thus, it may be stated that the 
basic imaging requirements are already available for the evaluation and follow-up of new disease 
modifying drugs leading to a more personalized medicine. Recent advances in sensor technology, i.e., 
magnets,  improved  gradient  performance,  and  multi  coil  RF  technology  may  also  enable  one  to 
achieve ultra short echo times (TE ≤ 0.2 ms) that can significantly improve resolution and SNR in 
sodium imaging. These advances may potentially make clinical sodium MRI feasible on 3 T scanners. 
Further, the recent increase in number of 7 T whole-body MRI scanners in clinical research centres 
could have a significant impact on sodium MRI and its potential for clinical use. Since SNR scales as 
B0
7/4 [2,132,133] there is a lack of B1 penetration and B0 inhomogeneity, issues that pose serious 
problems with proton imaging, and sodium MRI could be particularly advantageous at higher fields. 
Thus, 
23Na MRI at 7 T may become clinically useful and has the potential to become a new standard in 
biochemical  imaging  of  articular  cartilage  with  its  direct  correlation  to  glycosaminoglycan 
concentration, the component of the ultra-structure of cartilage, which is lost in the earliest stages of 
OA and plays the most important role in the biomechanical properties of cartilage. This would carry 
MR-based diagnosis from current 
1H-MRI to techniques measuring parameters more closely related to 
tissue metabolism. 
In summary, high-resolution 
1H-MRI, SWI, fMRI, 
23Na-MRI and 
31P-MRS show great potential for 
further  methodological  improvements  and  both,  research  and  clinical  applications.  A  serious 
constraint,  however,  is  posed  by  financial  limits  and  capacity,  including  specialized  training  of 
scientists and physicians, which have to be addressed in order to not only develop potentially useful Sensors 2010, 10                        
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diagnostic sensors and techniques but also to make these suitable for as many people as possible, 
tailored to individual patient’s needs. 
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